Contact
Please use this form to send email to PR contact of this press release:
Rapid Dose Provides Bi-Weekly Status Report Regarding MCTO and Update Regarding Interim Financial Statements
TO:
MARK A UPSDELL
Rapid Dose Therapeutics Corp.
+ 16472004709